Targeting tumor vasculature through oncolytic virotherapy: recent advances

Por Toro Bejarano, Marcela, Merchan, Jaime R
Publicado no Oncolytic Virother (2015)

In vivo antimetastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer

Por Jing, Yuqi, Bejarano, Marcela Toro, Zaias, Julia, Merchan, Jaime R.
Publicado no Breast Cancer Res Treat (2014)

In Vivo Safety, Biodistribution and Antitumor Effects of uPAR Retargeted Oncolytic Measles Virus in Syngeneic Cancer Models

Por Jing, Yuqi, Zaias, Julia, Duncan, Robert, Russell, Stephen J., Merchan, Jaime R.
Publicado em 2014

ROLE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN UROKINASE’S PARADOXICAL IN VIVO TUMOR SUPPRESSING OR PROMOTING EFFECTS

Por Jing, Yuqi, Kovacs, Krisztina, Kurisetty, Vittal, Jiang, Zhijie, Tsinoremas, Nick, Merchan, Jaime R.
Publicado em 2012

Combined Histone Deacetylase and Cyclooxygenase Inhibition Achieves Enhanced Antiangiogenic Effects in Lung Cancer Cells

Por Wang, Xiaoqi, Li, Guangyuan, Wang, Antai, Zhang, Zhenfeng, Merchan, Jaime R, Halmos, Balazs
Publicado em 2011

TUMOR AND VASCULAR TARGETING OF A NOVEL ONCOLYTIC MEASLES VIRUS RETARGETED AGAINST THE UROKINASE RECEPTOR

Por Jing, Yuqi, Tong, Caili, Zhang, Jin, Nakamura, Takafumi, Iankov, Ianko, Russell, Stephen J., Merchan, Jaime R.
Publicado em 2009

Molecular Effects of Stromal Selective Targeting by uPAR Retargeted Oncolytic Virus in Breast Cancer

Por Jing, Yuqi, Chavez, Valery, Ban, Yuguang, Acquavella, Nicolas, El-Ashry, Doraya, Pronin, Alexey, Chen, Xi, Merchan, Jaime R.
Publicado no Mol Cancer Res (2017)

A Phase I Clinical, Pharmacokinetic and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors

Por Montero, Alberto J., Kwon, Deukwoo, Flores, Aurea, Kovacs, Krisztina, Trent, Jonathan, Benedetto, Pasquale, Rocha-Lima, Caio, Merchan, Jaime R.
Publicado no Clin Cancer Res (2016)

2-DEOXY-GLUCOSE DOWN REGULATES ENDOTHELIAL AKT AND ERK VIA INTERFERENCE WITH N-LINKED GLYCOSYLATION, INDUCTION OF ENDOPLASMIC RETICULUM STRESS AND GSK-3β ACTIVATION

Por Kovács, Krisztina, Decatur, Christina, Toro, Marcela, Pham, Dien G., Liu, Huaping, Jing, Yuqi, Murray, Timothy G., Lampidis, Theodore J., Merchan, Jaime R.
Publicado no Mol Cancer Ther (2015)

Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress

Por Liu, Huaping, Kurtoglu, Metin, León-Annicchiarico, Clara Lucia, Munoz-Pinedo, Cristina, Barredo, Julio, Leclerc, Guy, Merchan, Jaime, Liu, Xiongfei, Lampidis, Theodore J.
Publicado no Oncotarget (2016)

SAFETY AND ACTIVITY OF TEMSIROLIMUS AND BEVACIZUMAB IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA PREVIOUSLY TREATED WITH TYROSINE KINASE INHIBITORS: A PHASE 2 CONSORTIUM STUDY

Por Merchan, Jaime R., Qin, Rui, Pitot, Henry, Picus, Joel, Liu, Glenn, Fitch, Tom, Maples, William J., Flynn, Patrick J., Fruth, Briant F., Erlichman, Charles
Publicado no Cancer Chemother Pharmacol (2015)

Antiangiogenic Activity of 2-Deoxy-D-Glucose

Por Merchan, Jaime R., Kovács, Krisztina, Railsback, Jaclyn W., Kurtoglu, Metin, Jing, Yuqi, Piña, Yolanda, Gao, Ningguo, Murray, Timothy G., Lehrman, Mark A., Lampidis, Theodore J.
Publicado em 2010

TMOD-15. TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN CNS METASTATIC BREAST CANCER

Por Inagaki, Akihito, Richardson, Angela M, Collins, Sara A, Hiraoka, Kei, Kamijima, Shuichi, Shorr, Jolene, Gruber, Harry, Jolly, Douglas, Merchan, Jaime, Slingerland, Joyce M, Kasahara, Noriyuki
Publicado no Neuro Oncol (2017)

Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumo...

Por Houston, Samuel K, Piña, Yolanda, Murray, Timothy G, Boutrid, Hinda, Cebulla, Colleen, Schefler, Amy C, Shi, Wei, Celdran, Magda, Feuer, William, Merchan, Jaime, Lampidis, Ted J
Publicado em 2011

PRECLINICAL SAFETY AND ACTIVITY OF RECOMBINANT VSV-IFN-B IN AN IMMUNOCOMPETENT MODEL OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Por Kurisetty, Vittal VS, Heiber, Joshua, Myers, Rae, Pereira, Guilherme S., Goodwin, Jarrard W., Federspiel, Mark J., Russell, Stephen J., Peng, Kah Whye, Barber, Glen, Merchan, Jaime R.
Publicado em 2014

The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma

Por Palacio, Sofia, Hosein, Peter J., Reis, Isildinha, Akunyili, Ikechukwu I., Ernani, Vinicius, Pollack, Terri, Macintyre, Jessica, Restrepo, Maria H., Merchan, Jaime R., Rocha Lima, Caio M.
Publicado no J Gastrointest Oncol (2018)

15-hydroxyprostaglandin dehydrogenase is a target of HNF3β and a tumor suppressor in lung cancer

Por Huang, Guosheng, Eisenberg, Rosana, Yan, Min, Monti, Stefano, Lawrence, Earl, Fu, Pingfu, Walbroehl, Jaclyn, Löwenberg, Ester, Golub, Todd, Merchan, Jaime, Tenen, Daniel G., Markowitz, Sanford, Halmos, Balazs
Publicado em 2008

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

Por Hosein, Peter J, Macintyre, Jessica, Kawamura, Carolina, Maldonado, Jennifer Cudris, Ernani, Vinicius, Loaiza-Bonilla, Arturo, Narayanan, Govindarajan, Ribeiro, Afonso, Portelance, Lorraine, Merchan, Jaime R, Levi, Joe U, Rocha-Lima, Caio M
Publicado em 2012

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Por Maynard, Sharon E., Min, Jiang-Yong, Merchan, Jaime, Lim, Kee-Hak, Li, Jianyi, Mondal, Susanta, Libermann, Towia A., Morgan, James P., Sellke, Frank W., Stillman, Isaac E., Epstein, Franklin H., Sukhatme, Vikas P., Karumanchi, S. Ananth
Publicado em 2003